|
| 37777995 | Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder. | Int Urol Nephrol | 2024 |
| 37951531 | Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors. | Mol Cell Endocrinol | 2024 |
| 35946088 | Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors. | Int J Surg Pathol | 2023 |
| 37558687 | Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid. | Sci Rep | 2023 |
| 37892063 | Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues. | Diagnostics (Basel) | 2023 |
| 37938166 | Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors. | Acta Oncol | 2023 |
| 37644036 | Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 |
| 37057870 | Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15â¿¿412 tumors. | Pathol Int | 2023 |
| 37179317 | An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9. | BMC Cancer | 2023 |
| 36980510 | Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland. | Diagnostics (Basel) | 2023 |
| 37379306 | CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas. | PLoS One | 2023 |
| 36976297 | BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial Orchestration. | Mol Cancer Res | 2023 |
| 36997051 | Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder. | Exp Mol Pathol | 2023 |
| 36656126 | Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry. | J Pathol | 2023 |
| 36788088 | Nonredundant Upregulation of CD112R (PVRIG) and PD-1 on Cytotoxic T Lymphocytes Located in T Cell Nests of Colorectal Cancer. | Mod Pathol | 2023 |
| 36649695 | GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors. | Pathobiology | 2023 |
| 36644936 | Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma. | Clin Chem | 2023 |
| 36683495 | PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples. | Cancer Biomark | 2023 |
| 36728364 | High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer. | Appl Immunohistochem Mol Morphol | 2023 |
| 36269681 | Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors. | APMIS | 2023 |
| 35917493 | SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15â¿¿000 Tumors. | Arch Pathol Lab Med | 2023 |
| 33414516 | CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo. | Cancer Gene Ther | 2022 |
| 35550834 | Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology. | Hum Pathol | 2022 |
| 35477165 | Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors. | Pathobiology | 2022 |
| 35764407 | Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma. | Int J Immunopathol Pharmacol | 2022 |
| 35642329 | DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer. | Histol Histopathol | 2022 |
| 35606285 | Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16. | Urol Oncol | 2022 |
| 35390310 | Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. | Exp Mol Pathol | 2022 |
| 35862385 | High prevalence of p16 staining in malignant tumors. | PLoS One | 2022 |
| 35449481 | Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes. | Ann Surg Oncol | 2022 |
| 35872365 | Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer. | Pathol Res Pract | 2022 |
| 35999270 | Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature. | Br J Cancer | 2022 |
| 36137400 | Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors. | Pathol Res Pract | 2022 |
| 35866621 | Villin expression in human tumors: a tissue microarray study on 14,398 tumors. | Expert Rev Mol Diagn | 2022 |
| 35992051 | Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors. | Anal Cell Pathol (Amst) | 2022 |
| 36029589 | Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors. | Ann Diagn Pathol | 2022 |
| 36292206 | Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells. | Diagnostics (Basel) | 2022 |
| 35921917 | Synaptophysin and chromogranin A expression analysis in human tumors. | Mol Cell Endocrinol | 2022 |
| 36289769 | Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors. | Biomedicines | 2022 |
| 35951102 | FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors. | Virchows Arch | 2022 |
| 35920686 | Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer. | Clin Cancer Res | 2022 |
| 36152841 | GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder. | Hum Pathol | 2022 |
| 36077784 | T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer. | Cancers (Basel) | 2022 |
| 36375372 | Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors. | Pathol Res Pract | 2022 |
| 34889867 | Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. | Am J Surg Pathol | 2022 |
| 35091676 | Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence. | Lab Invest | 2022 |
| 35267575 | PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power. | Cancers (Basel) | 2022 |
| 34625909 | 6q deletion is frequent but unrelated to patient prognosis in breast cancer. | Breast Cancer | 2022 |
| 34559291 | Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications. | Virchows Arch | 2022 |
| 32303902 | High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma. | World J Urol | 2021 |